> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Spirair Nasal Septal Deviation Device Cleared
- URL: https://www.fdaweb.com/spirair-nasal-septal-deviation-device-cleared/
- Published: 2024-04-08T12:00:00.000Z
- Updated: 2026-09-14T14:27:44.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156723

FDA has cleared a Spirair 510(k) for its SeptAlign system for treating nasal septal deviation (NSD), a “minimally invasive treatment that can be safely and conveniently performed under local anesthesia,” according to the company. “The bioabsorbable SeptAlign implant is inserted in the cartilage near the front of the nose and holds the straightened septum under tension, dissolving within six months,” it says, adding that studies have shown that NSD correction can improve nasal breathing, and cartilage can maintain a new shape after being held under tension by absorbable implants.